Welcome!

News Feed Item

Cardiac Arrest Global Clinical Trials Review, H1, 2014

NEW YORK, Feb. 12, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Cardiac Arrest Global Clinical Trials Review, H1, 2014
http://www.reportlinker.com/p0869179/Cardiac-Arrest-Global-Clinical-Trials-Review-H1-2014.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

Cardiac Arrest Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, "Cardiac Arrest Global Clinical Trials Review, H1, 2014" provides data on the Cardiac Arrest clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cardiac Arrest. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cardiac Arrest. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Cardiac Arrest 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Cardiac Arrest to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Cardiac Arrest to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Cardiac Arrest 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Cardiac Arrest Therapeutics Clinical Trials 30
Prominent Drugs 32
Latest Clinical Trials News on Cardiac Arrest 33
Nov 07, 2012: Metformin Offers Cardio Benefits Over Sulfonylureas In Diabetes, Study Finds 33
Aug 22, 2012: NIH Launches Trial To Evaluate Anti-inflammatory Treatment For Preventing Heart Attacks, Strokes, And Cardiovascular Deaths 33
Aug 22, 2012: Brigham And Women's Hospital Researchers Initiate Major Cardiovascular Inflammation Reduction Trial Using Teva's Trexall 34
Mar 25, 2012: Infusion Of Abciximab Into Coronary Artery May Reduce Size Of Heart Damage After Heart Attack 35
Nov 13, 2011: Anti-Clotting Drug Lowers Risks In Acute Coronary Syndrome Treatment 36
Clinical Trial Profiles 37
Clinical Trial Overview of Top Companies 37
Janssen Global Services, LLC 37
Clinical Trial Overview of Janssen Global Services, LLC 37
Boston Scientific Corporation 38
Clinical Trial Overview of Boston Scientific Corporation 38
Biotronik SE & Co. KG 39
Clinical Trial Overview of Biotronik SE & Co. KG 39
PT Dexa Medica 40
Clinical Trial Overview of PT Dexa Medica 40
Johnson & Johnson 41
Clinical Trial Overview of Johnson & Johnson 41
Janssen-Cilag A.G. 42
Clinical Trial Overview of Janssen-Cilag A.G. 42
C. H. Boehringer Sohn AG & Co. KG 43
Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 43
Clinical Trial Overview of Top Institutes / Government 44
Ottawa Hospital Research Institute 44
Clinical Trial Overview of Ottawa Hospital Research Institute 44
University of Washington 45
Clinical Trial Overview of University of Washington 45
National Heart, Lung, and Blood Institute 46
Clinical Trial Overview of National Heart, Lung, and Blood Institute 46
Kyoto University 47
Clinical Trial Overview of Kyoto University 47
Medical University of Vienna 48
Clinical Trial Overview of Medical University of Vienna 48
University of Pennsylvania 49
Clinical Trial Overview of University of Pennsylvania 49
Sunnybrook Health Sciences Centre 50
Clinical Trial Overview of Sunnybrook Health Sciences Centre 50
Assistance Publique - Hopitaux de Paris 51
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 51
University Hospital Basel 52
Clinical Trial Overview of University Hospital Basel 52
National Taiwan University Hospital 53
Clinical Trial Overview of National Taiwan University Hospital 53
Five Key Clinical Profiles 54
Appendix 74
Abbreviations 74
Definitions 74
Research Methodology 76
Secondary Research 76
About GlobalData 77
Contact Us 77
Disclaimer 77
Source 78

List of Tables

Cardiac Arrest Therapeutics, Global, Clinical Trials by Region, 2014* 7
Cardiac Arrest Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Cardiac Arrest Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Cardiac Arrest Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Cardiac Arrest Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Cardiac Arrest Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Cardiac Arrest Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Cardiac Arrest Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Cardiac Arrest to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Cardiac Arrest Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Cardiac Arrest Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Cardiac Arrest to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Cardiac Arrest Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Cardiac Arrest Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Cardiac Arrest Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Cardiac Arrest Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Cardiac Arrest Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Cardiac Arrest Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Cardiac Arrest Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Cardiac Arrest Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Cardiac Arrest Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Cardiac Arrest Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Cardiac Arrest Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Cardiac Arrest Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Cardiac Arrest Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Global Services, LLC, 2014* 37
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Scientific Corporation, 2014* 38
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by Biotronik SE & Co. KG, 2014* 39
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by PT Dexa Medica, 2014* 40
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014* 41
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen-Cilag A.G., 2014* 42
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014* 43
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by Ottawa Hospital Research Institute, 2014* 44
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014* 45
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 46
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2014* 47
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014* 48
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2014* 49
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by Sunnybrook Health Sciences Centre, 2014* 50
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014* 51
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Basel, 2014* 52
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014* 53

List of Figures

Cardiac Arrest Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Cardiac Arrest Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Cardiac Arrest Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Cardiac Arrest Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Cardiac Arrest Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Cardiac Arrest Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Cardiac Arrest Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Cardiac Arrest to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Cardiac Arrest Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Cardiac Arrest Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Cardiac Arrest to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Cardiac Arrest Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Cardiac Arrest Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Cardiac Arrest Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Cardiac Arrest Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Cardiac Arrest Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Cardiac Arrest Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Cardiac Arrest Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Cardiac Arrest Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Cardiac Arrest Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Cardiac Arrest Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
GlobalData Methodology 76

To order this report: Cardiac Arrest Global Clinical Trials Review, H1, 2014
http://www.reportlinker.com/p0869179/Cardiac-Arrest-Global-Clinical-Trials-Review-H1-2014.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Without a clear strategy for cost control and an architecture designed with cloud services in mind, costs and operational performance can quickly get out of control. To avoid multiple architectural redesigns requires extensive thought and planning. Boundary (now part of BMC) launched a new public-facing multi-tenant high resolution monitoring service on Amazon AWS two years ago, facing challenges and learning best practices in the early days of the new service. In his session at 19th Cloud Exp...
"We build IoT infrastructure products - when you have to integrate different devices, different systems and cloud you have to build an application to do that but we eliminate the need to build an application. Our products can integrate any device, any system, any cloud regardless of protocol," explained Peter Jung, Chief Product Officer at Pulzze Systems, in this SYS-CON.tv interview at @ThingsExpo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
The cloud promises new levels of agility and cost-savings for Big Data, data warehousing and analytics. But it’s challenging to understand all the options – from IaaS and PaaS to newer services like HaaS (Hadoop as a Service) and BDaaS (Big Data as a Service). In her session at @BigDataExpo at @ThingsExpo, Hannah Smalltree, a director at Cazena, provided an educational overview of emerging “as-a-service” options for Big Data in the cloud. This is critical background for IT and data professionals...
Internet of @ThingsExpo has announced today that Chris Matthieu has been named tech chair of Internet of @ThingsExpo 2017 New York The 7th Internet of @ThingsExpo will take place on June 6-8, 2017, at the Javits Center in New York City, New York. Chris Matthieu is the co-founder and CTO of Octoblu, a revolutionary real-time IoT platform recently acquired by Citrix. Octoblu connects things, systems, people and clouds to a global mesh network allowing users to automate and control design flo...
You are moving to the Cloud. The question is not if, it’s when. Now that your competitors are in the cloud and lapping you, your “when” better hurry up and get here. But saying and doing are two different things. In his session at @DevOpsSummit at 18th Cloud Expo, Robert Reeves, CTO of Datical, explained how DevOps can be your onramp to the cloud. By adopting simple, platform independent DevOps strategies, you can accelerate your move to the cloud. Spoiler Alert: He also makes sure you don’t...
President Obama recently announced the launch of a new national awareness campaign to "encourage more Americans to move beyond passwords – adding an extra layer of security like a fingerprint or codes sent to your cellphone." The shift from single passwords to multi-factor authentication couldn’t be timelier or more strategic. This session will focus on why passwords alone are no longer effective, and why the time to act is now. In his session at 19th Cloud Expo, Chris Webber, security strateg...
"We are an all-flash array storage provider but our focus has been on VM-aware storage specifically for virtualized applications," stated Dhiraj Sehgal of Tintri in this SYS-CON.tv interview at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
Redis is not only the fastest database, but it has become the most popular among the new wave of applications running in containers. Redis speeds up just about every data interaction between your users or operational systems. In his session at 18th Cloud Expo, Dave Nielsen, Developer Relations at Redis Labs, shared the functions and data structures used to solve everyday use cases that are driving Redis' popularity.
The WebRTC Summit New York, to be held June 6-8, 2017, at the Javits Center in New York City, NY, announces that its Call for Papers is now open. Topics include all aspects of improving IT delivery by eliminating waste through automated business models leveraging cloud technologies. WebRTC Summit is co-located with 20th International Cloud Expo and @ThingsExpo. WebRTC is the future of browser-to-browser communications, and continues to make inroads into the traditional, difficult, plug-in web co...
Enterprise IT has been in the era of Hybrid Cloud for some time now. But it seems most conversations about Hybrid are focused on integrating AWS, Microsoft Azure, or Google ECM into existing on-premises systems. Where is all the Private Cloud? What do technology providers need to do to make their offerings more compelling? How should enterprise IT executives and buyers define their focus, needs, and roadmap, and communicate that clearly to the providers?
Amazon has gradually rolled out parts of its IoT offerings, but these are just the tip of the iceberg. In addition to optimizing their backend AWS offerings, Amazon is laying the ground work to be a major force in IoT - especially in the connected home and office. In his session at @ThingsExpo, Chris Kocher, founder and managing director of Grey Heron, explained how Amazon is extending its reach to become a major force in IoT by building on its dominant cloud IoT platform, its Dash Button strat...
"We are a custom software development, engineering firm. We specialize in cloud applications from helping customers that have on-premise applications migrating to the cloud, to helping customers design brand new apps in the cloud. And we specialize in mobile apps," explained Peter Di Stefano, Vice President of Marketing at Impiger Technologies, in this SYS-CON.tv interview at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
Complete Internet of Things (IoT) embedded device security is not just about the device but involves the entire product’s identity, data and control integrity, and services traversing the cloud. A device can no longer be looked at as an island; it is a part of a system. In fact, given the cross-domain interactions enabled by IoT it could be a part of many systems. Also, depending on where the device is deployed, for example, in the office building versus a factory floor or oil field, security ha...
In addition to all the benefits, IoT is also bringing new kind of customer experience challenges - cars that unlock themselves, thermostats turning houses into saunas and baby video monitors broadcasting over the internet. This list can only increase because while IoT services should be intuitive and simple to use, the delivery ecosystem is a myriad of potential problems as IoT explodes complexity. So finding a performance issue is like finding the proverbial needle in the haystack.
The idea of comparing data in motion (at the sensor level) to data at rest (in a Big Data server warehouse) with predictive analytics in the cloud is very appealing to the industrial IoT sector. The problem Big Data vendors have, however, is access to that data in motion at the sensor location. In his session at @ThingsExpo, Scott Allen, CMO of FreeWave, discussed how as IoT is increasingly adopted by industrial markets, there is going to be an increased demand for sensor data from the outermos...